RTX-224 Monotherapy in Patients With Solid Tumors

Clinical trial NCT05219578 · TERMINATED

Trial details

NCT number: NCT05219578
Sponsor: Rubius Therapeutics
Status: TERMINATED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Non Small Cell Lung Cancer Cutaneous Melanoma Head and Neck Squamous Cell Carcinoma Urothelial Carcinoma TNBC - Triple-Negative Breast Cancer

Start date: 2022-01-12
Primary completion: 2022-11-30
Enrollment: 7

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.